Osmotica Pharmaceutical Corp recalls Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC

Recalled March 14, 2018 · FDA recall D-0581-2018 · Osmotica Pharmaceutical

Hazard

Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet. · FDA Class III

Units

19,664 100-bottles

Sold at

Nationwide in the USA

Description

Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.

Product

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

Manufacturer(s)

Osmotica Pharmaceutical Corp

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →